Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-individual cross-over comparison of MultiHance and Vasovist enhanced MRA of the carotids
2008-003669-24Phase 3Completed
- Sponsor
- German Cancer Research Center
- Start
- Jul 2008
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of gadofosveset and gadobenate dimeglumine in carotid atheroma (CAS) (2 arms), sponsored by German Cancer Research Center. Primary endpoint: Visibility of supraaortic vessel segments (patient-based assessment). Started Jul 2008; status: completed.
02
Drugs
gadofosvesetgadobenate dimeglumine
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on 2008-003669-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003669-24.